Application 020701

Type
NDA
Sponsor
ALLERGAN

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001CRINONEPROGESTERONEGEL;VAGINAL4%YesYes
002CRINONEPROGESTERONEGEL;VAGINAL8%YesYes

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
0023-6150CrinoneprogesteroneAllergan, Inc.NDACurrent
0023-6151CrinoneprogesteroneAllergan, Inc.NDACurrent
52544-255CrinoneprogesteroneActavis Pharma, Inc.NDACurrent
52544-256CrinoneprogesteroneActavis Pharma, Inc.NDACurrent
55056-0406ProchieveprogesteroneColumbia LaboratoriesNDACurrent
55056-0806CrinoneprogesteroneColumbia Laboratories, Inc.NDACurrent
55056-0808CrinoneprogesteroneColumbia Laboratories, Inc.NDACurrent
55056-0818CrinoneprogesteroneColumbia Laboratories, Inc.NDACurrent
55056-1601ProchieveprogesteroneColumbia LaboratoriesNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
13242SUPPL2013-08-22
35168SUPPL2011-12-14
35167SUPPL2011-12-14
25564SUPPL2011-12-14
13241SUPPL2011-12-14
3123SUPPL2011-12-14
3122SUPPL2011-12-14
41580SUPPL2007-11-19
13240SUPPL2005-03-29
3121SUPPL2005-03-29
25563SUPPL2003-11-26
3120SUPPL2003-09-29
41579ORIG2003-08-08
3119SUPPL2001-04-23
25562SUPPL2001-04-11